About V-Ensure Pharma Technologies
V-Ensure Pharma Technologies is a company based in Navi Mumbai (India) founded in 2010 by Sathyanarayana Vemula. V-Ensure Pharma Technologies has raised $17.4 million across 1 funding round from investors including Investcorp and Tanas Capital. V-Ensure Pharma Technologies offers products and services including Formulation R&D, API R&D, Analytical Services, cGMP Manufacturing, and Injectable Products. V-Ensure Pharma Technologies operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Navi Mumbai, India
- Founders Sathyanarayana Vemula
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name V-Ensure Pharma Technologies Private Limited
- Date of Incorporation 26 Jul, 2010
-
Annual Revenue
$4.88 M (USD)-1.95as on Mar 31, 2023
-
Net Profit
$435.68 K (USD)-47.26as on Mar 31, 2023
-
EBITDA
$723.92 K (USD)-70.21as on Mar 31, 2023
-
Total Equity Funding
$17.4 M (USD)
in 1 rounds
-
Latest Funding Round
$17.4 M (USD), Private Equity Round
Feb 21, 2022
-
Investors
Investcorp
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of V-Ensure Pharma Technologies
V-Ensure Pharma Technologies offers a comprehensive portfolio of products and services, including Formulation R&D, API R&D, Analytical Services, cGMP Manufacturing, and Injectable Products.
Research for pharmaceutical formulations and processes.
Development of active pharmaceutical ingredients.
Quality analysis for pharmaceutical products.
Production of pharmaceuticals under good practices.
Manufacturing of injectable drugs for medical use.
Production of solid oral medications.
Manufacturing of liquid oral formulations.
People of V-Ensure Pharma Technologies
Unlock access to complete
Funding Insights of V-Ensure Pharma Technologies
V-Ensure Pharma Technologies has successfully raised a total of $17.4M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $17.4 million completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in V-Ensure Pharma Technologies
V-Ensure Pharma Technologies has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Investcorp and Tanas Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity, real estate, and credit investments are managed globally.
|
Locked | Locked | Locked | |
|
Private equity firm focused on multiple assets
|
Locked | Locked | Locked |
Investor details for V-Ensure Pharma Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by V-Ensure Pharma Technologies
Investment portfolio details for V-Ensure Pharma Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - V-Ensure Pharma Technologies
Detailed financials for V-Ensure Pharma Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
V-Ensure Pharma Technologies Comparisons
Peer comparison for V-Ensure Pharma Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of V-Ensure Pharma Technologies
V-Ensure Pharma Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of V-Ensure Pharma Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on V-Ensure Pharma Technologies
Complete news archive for V-Ensure Pharma Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about V-Ensure Pharma Technologies
V-Ensure Pharma Technologies was founded in 2010 and raised its 1st funding round 12 years after it was founded.
V-Ensure Pharma Technologies is headquartered in Navi Mumbai, India. It is registered at Navi Mumbai, Maharashtra, India.
Sathyanarayana Vemula is the current CEO of V-Ensure Pharma Technologies. They have also founded this company.
V-Ensure Pharma Technologies is a funded company, having raised a total of $17.4M across 1 funding round to date.
Annual revenue of V-Ensure Pharma Technologies is $4.88M as on Mar 31, 2023.
V-Ensure Pharma Technologies was established in 2010 in Navi Mumbai, India. Focus is placed on the pharmaceutical sector as a contract development and manufacturing organization. Active pharmaceutical ingredients are produced through dedicated operations. Services encompass API manufacturing for various clients. The company operates from its base in India, supporting global pharmaceutical needs with established processes. Leadership is provided by founder Sathyanarayana Vemula as CEO.
V-Ensure Pharma Technologies's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
V-Ensure Pharma Technologies offers Formulation R&D, API R&D, Analytical Services, cGMP Manufacturing, and 3 more products and services.
V-Ensure Pharma Technologies has 2 investors. Key investors include Investcorp, and Tanas Capital.
The valuation of V-Ensure Pharma Technologies is $58.29M as of Feb 2022.